BRNS

COM:BARINTHUSBIO

Barinthus Biotherapeutics plc

Stock

USD

Last Close

0.98

22/11 21:00

Market Cap

55.90M

Beta: -

Volume Today

142.16K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-20.82M -	-17.93M 13.85%	-51.11M 185.02%	5.32M 110.41%
depreciation and amortization	346.86K -	208K 40.03%	602K 189.42%	4.32M 618.11%
deferred income tax		-2.49M -	-119K 95.22%	-4.34M 3,544.54%
stock based compensation		3.63M -	16.49M 354.81%	9.88M 40.09%
change in working capital	2.94M -	1.92M 34.60%	-7.18M 473.47%	-5.52M 23.04%
accounts receivables	-963.16K -	479K 149.73%	559K 16.70%	-5.83M 1,143.47%
inventory	-0.00 -	889K 190,911,296,307,200,096%	-4.15M 566.37%	-648K 84.37%
accounts payables	2.98M -	586K 80.32%	-3.53M 702.05%	1.14M 132.31%
other working capital	924.57K -	-32K 103.46%	-63K 96.88%	-183K 190.48%
other non cash items	-1.23M -	3.64M 395.78%	8.74M 140.23%	-24.09M 375.74%
net cash provided by operating activities	-18.76M -	-11.03M 41.21%	-32.58M 195.46%	-14.43M 55.71%	-50.92M 252.89%
investments in property plant and equipment	-128.35K -	-293K 128.29%	-1.15M 291.13%	-6.14M 435.60%
acquisitions net	2.06M -	252.89K 87.70%	-11.77M 4,752.62%	387.76K 103.30%
purchases of investments
sales maturities of investments
other investing activites		-252.89K -		240 -	-5.41M 2,255,516.67%
net cash used for investing activites	1.93M -	-293K 115.20%	-12.91M 4,306.83%	-5.75M 55.47%	-5.41M 5.86%
debt repayment		-41.50M -		-159K -
common stock issued	1.00 -	49.38 4,817.76%	102.77M 208,123,770.05%	484K 99.53%
common stock repurchased
dividends paid
other financing activites		82.94M -	119.97M 44.65%		1.87M -
net cash used provided by financing activities	1.00 -	41.44M 4,126,420,644.54%	222.74M 437.57%	325K 99.85%	1.87M 476%
effect of forex changes on cash	-0.15 -	1.72M 1,149,771,149.65%	-6.46M 475.52%	187K 102.90%	2.17M 1,060.96%
net change in cash	-16.83M -	31.83M 289.14%	170.79M 436.50%	-19.67M 111.52%	-52.30M 165.88%
cash at beginning of period	28.26M -	11.43M 59.55%	43.27M 278.46%	214.05M 394.74%
cash at end of period	11.43M -	43.27M 278.46%	214.05M 394.74%	194.38M 9.19%	-52.30M 126.90%
operating cash flow	-18.76M -	-11.03M 41.21%	-32.58M 195.46%	-14.43M 55.71%	-50.92M 252.89%
capital expenditure	-128.35K -	-293K 128.29%	-1.15M 291.13%	-6.14M 435.60%
free cash flow	-18.89M -	-11.32M 40.06%	-33.73M 197.93%	-20.57M 39.02%	-50.92M 147.58%

All numbers in USD (except ratios and percentages)